Lupin Ltd has received tentative approval from the United States Food and Drug Administration for its generic version of Sugammadex injection
Teva Pharmaceutical is accelerating its Teva’s biosimilars expansion with three major milestones that strengthen its “Pivot to Growth” strategy and reinforce its position in the global biosimilars market.
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its generic mental health drug — Paroxetine extended-release tablets, a medication commonly used to treat mental health conditions.
Novo Nordisk is set to cut the Ozempic price in India as Indian generics flood the market following the patent expiry.
India’s pharmaceutical industry is grappling with a severe raw material crisis, putting immense pressure on API producers. Prices of key chemicals and Active Pharmaceutical Ingredients (APIs) have skyrocketed, forcing manufacturers to cut production
Apollo Hospitals today announced a structured patient transfer initiative aimed at improving access to advanced critical care through coordinated air medical transportation across India and international regions.
Alembic Pharmaceuticals Limited has secured USFDA approval for Paroxetine Extended-Release Tablets USP 12.5 mg, marking another step forward in its growing U.S. generics portfolio.
Lupin Limited has received a USFDA tentative approval for daytime sleepiness drug, strengthening its position in the US generics market.
Government of India is stepping up its push for generic medicines in hospitals, urging healthcare providers to prescribe and stock low-cost alternatives to branded drugs.
AstraZeneca made a major move today with its experimental COPD drug tozorakimab, reporting that the treatment significantly reduced moderate to severe flare ups of chronic obstructive pulmonary disease (COPD) in two late stage Phase III trials.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")